A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT06767735 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

580

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GZR4
DRUG: Insulin Glargine U100

Sponsor

Gan & Lee Pharmaceuticals.